FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Toshiharu Kamura

Research Profile

Disorders

Chemicals & Drugs

Anatomy

T-Lymphocytes, Cytotoxic

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Geographic Areas

Japan

Co-author Network

Publications

TOP 3
Kimio Ushijima; Hidehiro Eto; Keizo Fujiyoshi; Kouichiro Kawano; Shin Nishio; Naotake Tsuda; Toshiharu Kamura
Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study.
Kimio Ushijima; Toru Sugiyama; Kazuo Tamura; Toshiharu Kamura; Kazuo Kuzuya; Kiichiro Noda; Kazunori Ochiai
Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study.
Shuji Takemoto; Atsumu Terada; Kimio Ushijima; Hiroko Wada; Kazumi Honda; Hiroto Imaishi; Toshiharu Kamura
Precise evaluation of chemotherapy-induced peripheral neuropathy using the visual analogue scale: a quantitative and comparative analysis of neuropathy occurring with paclitaxel-carboplatin and docetaxel-carboplatin therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Toshiharu Kamura (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kimio Ushijima; Hidehiro Eto; Keizo Fujiyoshi; Kouichiro Kawano; Shin Nishio; Naotake Tsuda; Toshiharu Kamura
Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study.
Journal of gynecologic oncology 2013;24(2):108-13.
2013: Kimio Ushijima; Toru Sugiyama; Kazuo Tamura; Toshiharu Kamura; Kazuo Kuzuya; Kiichiro Noda; Kazunori Ochiai
Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study.
International journal of clinical oncology 2013;18(1):126-31.
2012: Shuji Takemoto; Atsumu Terada; Kimio Ushijima; Hiroko Wada; Kazumi Honda; Hiroto Imaishi; Toshiharu Kamura
Precise evaluation of chemotherapy-induced peripheral neuropathy using the visual analogue scale: a quantitative and comparative analysis of neuropathy occurring with paclitaxel-carboplatin and docetaxel-carboplatin therapy.
International journal of clinical oncology 2012;17(4):367-72.
2012: Shuji Takemoto; Toshiharu Kamura
[Natural history, epidemiology and statistics of gynecologic cancers].
Nihon rinsho. Japanese journal of clinical medicine 2012;70 Suppl 4():5-9.
2012: Akimasa Fukui; Satoshi Hattori; Kyogo Itoh; Kouichiro Kawano; Nobukazu Komatsu; Satoko Matsueda; Tetsuro Sasada; Shigeki Shichijo; Naotake Tsuda; Kimio Ushijima; Toshiharu Kamura
Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides.
Virology journal 2012;9():199.
2011: Takashi Onda; Hiroyuki Yoshikawa; Ikuo Konishi; Toshiharu Kamura
The history of the Gynecologic Cancer Study Group (GCSG) of the Japan Clinical Oncology Group (JCOG).
Japanese journal of clinical oncology 2011;41(10):1156-61.
2011: Kouichiro Kawano; Kimio Ushijima; Masato Yokomine; Akimasa Fukui; Morio Ijichi; Toshiharu Kamura
A case of minimal uterine serous carcinoma with distant lymph node metastasis without peritoneal dissemination.
Journal of gynecologic oncology 2011;22(1):53-6.
2010: Shunichiro Ota; Kimio Ushijima; Naoki Fujiyoshi; Takefumi Fujimoto; Ryunosuke Hayashi; Fumihiro Murakami; Kan Komai; Keizo Fujiyoshi; Daizo Hori; Toshiharu Kamura
Desmoplastic small round cell tumor in the ovary: Report of two cases and literature review.
The journal of obstetrics and gynaecology research 2010;36(2):430-4.
2010: Isamu Saito; Ryo Kitagawa; H Fukuda; Taro Shibata; Noriyuki Katsumata; Ikuo Konishi; Hiroyuki Yoshikawa; Toshiharu Kamura
A phase III trial of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in stage IVB, persistent or recurrent cervical cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505).
Japanese journal of clinical oncology 2010;40(1):90-3.
2009: S Takemoto; Kimio Ushijima; Kouichiro Kawano; T Yamaguchi; A Terada; N Fujiyoshi; Shin Nishio; Naotake Tsuda; M Ijichi; T Kakuma; Masayoshi Kage; D Hori; Toshiharu Kamura
Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma.
British journal of cancer 2009;101(6):967-72.
2009: Shuji Takemoto; Kimio Ushijima; Kazumi Nakaso; Naoki Fujiyoshi; Toshiharu Kamura
Primary adenocarcinoma of the vagina successfully treated with neoadjuvant chemotherapy consisting of paclitaxel and carboplatin.
The journal of obstetrics and gynaecology research 2009;35(3):579-83.
2009: Shin Nishio; Hitoshi Tsuda; Naoki Fujiyoshi; Shun-Ichiro Ota; Kimio Ushijima; Yuko Sasajima; Takahiro Kasamatsu; Toshiharu Kamura; Osamu Matsubara
Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.
Pathology, research and practice 2009;205(5):331-7.
2008: Noriyuki Katsumata; Yasuhiro Fujiwara; Toshiharu Kamura; Toru Nakanishi; Masayuki Hatae; Daisuke Aoki; Kenichi Tanaka; Hiroshi Tsuda; Shoji Kamiura; Kazuhiro Takehara; Toru Sugiyama; Junzo Kigawa; Keiichi Fujiwara; Kazunori Ochiai; Ryo Ishida; Mitsuo Inagaki; Kiichiro Noda
Phase II clinical trial of pegylated liposomal doxorubicin (JNS002) in Japanese patients with mullerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of fallopian tube, peritoneal carcinoma) having a therapeutic history of platinum-based chemotherapy: a Phase II Study of the Japanese Gynecologic Oncology Group.
Japanese journal of clinical oncology 2008;38(11):777-85.
2008: Kimio Ushijima; Norio Wake; Hiroaki Kobayashi; Toru Hachisuga; Naoyuki Toki; Hideaki Masuzaki; Kohei Kotera; Tatsuhiko Kawarabayashi; Makoto Emoto; Toshiharu Kamura
[The efficacy and safety of indisetron hydrochloride for the management of nausea/vomiting caused by chemotherapy for gynecologic cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2008;35(7):1169-73.
2008: Shin Nishio; Kimio Ushijima; Naotake Tsuda; Shuji Takemoto; Kouichiro Kawano; Tomohiko Yamaguchi; Naoyo Nishida; Tatsuyuki Kakuma; Hitoshi Tsuda; Takahiro Kasamatsu; Yuko Sasajima; Masayoshi Kage; Michihiko Kuwano; Toshiharu Kamura
Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma.
Cancer letters 2008;264(1):36-43.
2007: Shin Nishio; Toru Sugiyama; Tadahiro Shouji; Akira Yoshizaki; Ryo Kitagawa; Kimio Ushijima; Toshiharu Kamura
Pilot study evaluating the efficacy and toxicity of irinotecan plus oral etoposide for platinum- and taxane-resistant epithelial ovarian cancer.
Gynecologic oncology 2007;106(2):342-7.
2007: Kimio Ushijima; Hideaki Yahata; Hiroyuki Yoshikawa; Ikuo Konishi; Toshiharu Yasugi; Toshiaki Saito; Toru Nakanishi; Hiroshi Sasaki; Fumitaka Saji; Tsuyoshi Iwasaka; Masayuki Hatae; Shoji Kodama; Tsuyoshi Saito; Naoki Terakawa; Nobuo Yaegashi; Masamichi Hiura; Atsuhiko Sakamoto; Hitoshi Tsuda; Masaharu Fukunaga; Toshiharu Kamura
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2798-803.
2007: Kouichiro Kawano; Kimio Ushijima; Takefumi Fujimoto; Kan Komai; Toshiharu Kamura
Peptide YY producing strumal carcinoid of the ovary as the cause of severe constipation with contralateral epithelial ovarian cancer.
The journal of obstetrics and gynaecology research 2007;33(3):392-6.
2007: Shunichiro Ota; Kimio Ushijima; Shin Nishio; Naoki Fujiyoshi; Shuji Takemoto; Atsumu Terada; Toshiharu Kamura
Polypoid endocervical adenomyoma: a case report with clinicopathologic analyses.
The journal of obstetrics and gynaecology research 2007;33(3):363-7.
2007: Toshiharu Kamura
Management of lymph nodes in the treatment of gynecologic cancers.
International journal of clinical oncology 2007;12(3):163-4.
2007: Go Matsuo; Kimio Ushijima; Atsuhiko Shinagawa; Syun-Ichi Takahashi; Naoki Fujiyoshi; Syuji Takemoto; Atsumu Terada; Akimasa Fukui; Toshiharu Kamura
GnRH agonist acts as ovarian protection in chemotherapy induced gonadotoxicity: an experiment using a rat model.
The Kurume medical journal 2007;54(1-2):25-9.
2006: Shin Nishio; Kimio Ushijima; Akimasa Fukui; Naoki Fujiyoshi; Kouichiro Kawano; Kan Komai; Shunichiro Ota; Keizo Fujiyoshi; Toshiharu Kamura
Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary.
The journal of obstetrics and gynaecology research 2006;32(4):416-21.
2006: Naoyo Nishida; Hirohisa Yano; Takashi Nishida; Toshiharu Kamura; Masamichi Kojiro
Angiogenesis in cancer.
Vascular health and risk management 2006;2(3):213-9.
2005: Miho Hara; Satoko Matsueda; Mayumi Tamura; Hiroko Takedatsu; Masahiro Tanaka; Kouichiro Kawano; Kazuo Mochizuki; Toshiharu Kamura; Kyogo Itoh; Mamoru Harada
Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancer.
International journal of oncology 2005;27(5):1371-9.
2004: Michihiko Kuwano; Yoshinao Oda; Hiroto Izumi; Song-Ju Yang; Takeshi Uchiumi; Yukihide Iwamoto; Masakazu Toi; Teruhiko Fujii; Hideaki Yamana; Hisafumi Kinoshita; Toshiharu Kamura; Masazumi Tsuneyoshi; Kosei Yasumoto; Kimitoshi Kohno
The role of nuclear Y-box binding protein 1 as a global marker in drug resistance.
Molecular cancer therapeutics 2004;3(11):1485-92.
2004: Yumi Takemoto; Hirohisa Yano; Seiya Momosaki; Sachiko Ogasawara; Naoyo Nishida; Sakiko Kojiro; Toshiharu Kamura; Masamichi Kojiro
Antiproliferative effects of interferon-alphaCon1 on ovarian clear cell adenocarcinoma in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(21):7418-26.
2004: Kan Komai; Toshiharu Kamura
[Staging and management for ovarian cancer].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 10():484-8.
2004: Kimio Ushijima; Toshiharu Kamura
[Cancer of the female genital tract--natural history, epidemiology, and biostatistics].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 10():9-16.
2004: Naoyo Nishida; Hirohisa Yano; Kan Komai; Takashi Nishida; Toshiharu Kamura; Masamichi Kojiro
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
Cancer 2004;101(6):1364-74.
2004: Kazuo Mochizuki; Yuji Sato; Naotake Tsuda; Hiroki Shomura; Masaru Sakamoto; Kimio Matsuura; Kimio Ushijima; Yoshiaki Maeda; Kazuko Katagiri; Akira Yamada; Satoru Todo; Toshiharu Kamura; Mamoru Harada; Kyogo Itoh
Immunological evaluation of vaccination with pre-designated peptides frequently selected as vaccine candidates in an individualized peptide vaccination regimen.
International journal of oncology 2004;25(1):121-31.
2004: Takashi Mine; Yuji Sato; Masanori Noguchi; Teruo Sasatomi; Rumi Gouhara; Naotake Tsuda; Shoko Tanaka; Hiroki Shomura; Kazuko Katagiri; Toru Rikimaru; Shigeki Shichijo; Toshiharu Kamura; Takashi Hashimoto; Kazuo Shirouzu; Akira Yamada; Satoru Todo; Kyogo Itoh; Hideaki Yamana
Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):929-37.
2004: Naotake Tsuda; Kazuo Mochizuki; Mamoru Harada; Aki Sukehiro; Koichiro Kawano; Akira Yamada; Kimio Ushijima; Toru Sugiyama; Takashi Nishida; Hideaki Yamana; Kyogo Itoh; Toshiharu Kamura
Vaccination with predesignated or evidence-based peptides for patients with recurrent gynecologic cancers.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(1):60-72.
2003: Shunichiro Ota; Lluis Catasus; Xavier Matias-Guiu; Elena Bussaglia; Helena Lagarda; Cristina Pons; Josefina Muñoz; Toshiharu Kamura; Jaime Prat
Molecular pathology of atypical polypoid adenomyoma of the uterus.
Human pathology 2003;34(8):784-8.
2003: Shin Nishio; Shunichiro Ota; Toru Sugiyama; Go Matsuo; Hidehiro Kawagoe; Seisuke Kumagai; Kimio Ushijima; Takashi Nishida; Toshiharu Kamura
Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer: a preliminary study.
International journal of clinical oncology 2003;8(1):45-8.
2003: Sakiko Kojiro; Yoshihito Tomioka; Yumi Takemoto; Naoyo Nishida; Toshiharu Kamura; Masamichi Kojiro
Primary leiomyoma of the ovary--a report of 2 resected cases.
The Kurume medical journal 2003;50(3-4):169-72.
2002: Toshiharu Kamura; Jin Dong Jeon
Lymph node metastasis in a gynecologic malignancy.
Yonsei medical journal 2002;43(6):783-91.
2002: Toshiharu Kamura; Young Tae Kim
Pitfall in chemotherapy for ovarian cancer.
Yonsei medical journal 2002;43(6):779-82.
2002: Naotake Tsuda; Yoichi Nonaka; Shigeki Shichijo; Akira Yamada; Masaaki Ito; Yoshiaki Maeda; Mine Harada; Toshiharu Kamura; Kyogo Itoh
UDP-Gal: betaGlcNAc beta1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour.
British journal of cancer 2002;87(9):1006-12.
2002: Yoichi Nonaka; Naotake Tsuda; Shigeki Shichijo; Masaaki Ito; Yoshiaki Maeda; Mine Harada; Toshiharu Kamura; M Shigemori; Kyogo Itoh
Recognition of ADP-ribosylation factor 4-like by HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes from patients with brain tumors.
Tissue antigens 2002;60(4):319-27.
2002: Yoshiaki Maeda; Naoya Hida; Fumihiko Niiya; Kazuko Katagiri; Mine Harada; Hideaki Yamana; Toshiharu Kamura; M Takahashi; Yuuji Sato; Satoru Todo; Kyogo Itoh
Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients.
British journal of cancer 2002;87(7):796-804.
2002: Kimio Ushijima; Syun-ichiro Ota; Kan Komai; Go Matsuo; Sigenobu Motoshima; Shizue Honda; Renpei Tomonari; Toru Sugiyama; Toshiharu Kamura
Clinical assessment of neoadjuvant chemotherapy and interval cytoreductive surgery for unresectable advanced ovarian cancer.
International surgery 2002;87(3):185-90.
2002: Toru Sugiyama; Michiaki Yakushiji; Toshiharu Kamura; Masanori Ikeda; Naohiko Umesaki; Kazuo Hasegawa; Mutsuo Ishikawa; Fumitaka Saji; Masamichi Hiura; Takeshi Takahashi; Shinji Sato; Kazunori Ochiai; Fumitaka Kikkawa; Shoshichi Takeuchi; Yasuo Ohashi; Kiichiro Noda
Irinotecan (CPT-11) and cisplatin as first-line chemotherapy for advanced ovarian cancer.
Oncology 2002;63(1):16-22.
2001: S Ota; Toru Sugiyama; Kan Komai; N Hirai; S Kumagai; Kimio Ushijima; Takashi Nishida; Toshiharu Kamura
Weekly 1 hour paclitaxel infusion in patients with recurrent gynecological tumors: a pilot study.
Japanese journal of clinical oncology 2001;31(8):395-8.
2001: Seisuke Kumagai; Keizo Fujiyoshi; Toru Sugiyama; Shunichiro Ota; O Yoshimura; Takashi Nishida; Toshiharu Kamura
[A modified administrated schedule for combination therapy with irinotecan and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical cancer--a report of 2 cases as a pilot study].
Gan to kagaku ryoho. Cancer & chemotherapy 2001;28(5):701-5.
2001: Shunichiro Ota; Toru Sugiyama; Kimio Ushijima; Keizo Fujiyoshi; Kan Komai; N Hirai; Takashi Nishida; Toshiharu Kamura
Remission of metastatic cervical adenocarcinoma with weekly paclitaxel.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2001;11(2):167-8.
2000: Shunichiro Ota; Toru Sugiyama; Kimio Ushijima; Kan Komai; Keizo Fujiyoshi; N Hirai; Takashi Nishida; Toshiharu Kamura
Successful treatment of two patients with recurrent endometrial cancer by weekly paclitaxel.
Cancer letters 2000;160(1):9-12.
2000: Shoko Tanaka; N Tsuda; Kouichiro Kawano; M Sakamoto; Takashi Nishida; T Hashimoto; Shigeki Shichijo; Toshiharu Kamura; Kyogo Itoh
Expression of tumor-rejection antigens in gynecologic cancers.
Japanese journal of cancer research : Gann 2000;91(11):1177-84.
2000: Kouichiro Kawano; SY Gomi; Koji Tanaka; Naotake Tsuda; Toshiharu Kamura; Kyogo Itoh; Akira Yamada
Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer.
Cancer research 2000;60(13):3550-8.
2000: Toru Sugiyama; Toshiharu Kamura; J Kigawa; N Terakawa; Y Kikuchi; T Kita; M Suzuki; I Sato; K Taguchi
Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy.
Cancer 2000;88(11):2584-9.
2000: Shin Nishio; Seisuke Kumagai; N Hirai; Y Tomioka; S Oota; Keizo Fujiyoshi; Y Hasuo; Toru Sugiyama; Takashi Nishida; Toshiharu Kamura
[Neoadjuvant chemotherapy with cisplatin and CPT-11 for advanced cervical cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27(3):429-35.
2000: Toru Sugiyama; Kimio Ushijima; Toshiharu Kamura
[New regimens for the treatment of gynecologic cancers].
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27(3):375-81.